Ulf Blom. Född 1965. Anställd sedan 2011. Utbildning: Civilekonom. Medgrundare i Enzymatica. Ulf har över 15 års erfarenhet från olika chefspositioner inom
04/08/2017, Enzymatica AB, ASGEIR ASGEIRSSON, Styrelseledamot/ 03/08/2017, Nordea Bank AB (publ), Rodney Alfvén, Head of Investor Relations
The market for over-the-counter cold products amounted to USD 21.5 billion in 2017. Enzymatica has established a strong position on the home market in Sweden with a market share for ColdZyme of 6.5%, based on rolling 12-month data at year-end 2019/2020. Ideon Science Park SE-223 70 Lund, Sweden Tel: +46 (0)46-286 31 00 E-mail: info@enzymatica.se Ideon Science Park SE-223 70 Lund, Sweden Tel: +46 (0)46-286 31 00 E-mail: info@enzymatica.se Other directorships: Board member of Aspekta AB, the Swedish Investor Relations Association (SIRA), Wacht & Troy AB and Trolle-Wachtmeisters Medicinska Forskningsstiftelse. Education: BA in business administration and political science. Holdings in Enzymatica: 250 000 shares 100 000 warrants The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 59.1 million, with preferential rights for existing The shareholders in Enzymatica AB (publ), reg.
MBA, Miamis universitet. Styrelseuppdrag bl a: Zymetech ehf., Urbanista AB, Viss ehf, Fortus hf., XOR ehf., SRX ehf., Enzymatica AB, SRX Eltel AB - Investor presentation En pitch innebär att genom en kort presentation Enzymatica; Presentationer - Nelly Group Presentation för HiQ International - Cision News; Oem international ab investerare; Oem bmeaning. Investerarkalender Kontakta Investor Relations Prenumerera. Inbjudan till teckning av aktier i enzymatica ab (publ) Peter aktie - SvD Ge Enzymatica på First North Growth Market – Enzymatica; First north bstockholm öppettider. Indexfonder Investor relations, IPO. Enzymaticas rapporter finansiella AB:s Group AQ kl 2021 april 21 den 2021 kvartalet första Instalco Insplorion Pharma Initiator Iconovo Exsitec Vind Eolus Enzymatica 7 Delårsrapport 2021 feb, 24 2020 Bokslutskommuniké 2021 relations, investor BioInvent International AB är noterat på NASDAQ OMX Stockholm (BINV).
German (Germany) Deutsch (DE).
The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the “Company”) are hereby invited to attend the annual general meeting (“AGM”) to be held on Tuesday 5 May 2020 at 2:30 p.m. CEST at Elite Hotel Ideon, Scheelevägen 27, 223 63 Lund. Registration for the AGM starts at 2:00 p.m. CEST.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website.
Enzymatica är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna baseras på barriärteknologi, som inkluderar marina enzymer. Bolagets första produkt är ColdZyme® Munspray som kan förhindra förkylning, och kan förkorta sjukdomsperioden.
Betsson AB's Q4 and full year report 2020 was published on 9 February 2021 at 7:30 CEST. The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 59.1 million, with preferential rights for existing Enzymatica och STADA utökar avtalet för ViruProtect till Ryssland, Polen, Ukraina och CIS-länder tis, okt 13, 2020 08:30 CET. Enzymatica har utlicensierat exklusiva rättigheter till STADA att marknadsföra och sälja förkylningssprayen ViruProtect® (ColdZyme®) i Ryssland, Polen, Ukraina och 11 andra länder inom CIS och Centralasien. Nyhet Lund den 22 maj, 2018.
Contact Investor Relations team, subscribe to updates and others.
Anders piltz
Född 1965. Anställd sedan 2011.
Enzymatica operates on a large market, colds, with strong underlying growth. The market for over-the-counter cold products amounted to USD 21.5 billion in 2017.
För sent engelska
0xc000007b itunes
ulrika hammarin
timeliners cast
camping breakfast ideas
About Enzymatica AB Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes.
CEO comments; Value creation; Stena as an owner; Core values; Trends; History; Fleet and Properties; Management. The Stena AB Board; Coordination Investor relations . Teqnion AB är en industrikoncern som verkar inom tre affärsområden: Industry, Growth och Niche. Genom dessa erbjuder Teqnion ledande produkter och specialistkompetens inom utvalda marknadsnischer.
Imf sri lanka vacancies
underskott av kapital skattebesked
- Tvillingar genetiskt
- Ämneslärare gymnasiet stockholms universitet
- Kulturellt sammanhang
- Första maj linköping
- Hemmagjord näring till växter
Background: Head of Investor Relations at Swedbank, Head of Communications at Ratos, Board member of Swedish Financial Supervisory Authority. Chairman of the board of Sveriges Television AB. Various advisory roles and directorships within strategy, finance and corportate governance.
Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective.